Results 121 to 130 of about 663,256 (217)

Tissue and peripheral T cell receptor repertoire predicts immunotherapy response and progression-free survival in NSCLC patients. [PDF]

open access: yesSci Rep
Pino-González M   +8 more
europepmc   +1 more source

Table S4 from Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy

open access: gold
Mingming Zhang   +15 more
openalex   +1 more source

Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma

open access: gold, 2017
Tzu Hua Chen‐Liang   +34 more
openalex   +1 more source

Impact of <i>TSC2</i> loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis. [PDF]

open access: yesFujita Med J
Ichikawa R   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy